Last reviewed · How we verify
NCT02814084: Prevena
Prevena Incision Management
NA trial testing Bilateral Internal Mammary Artery grafts in Cardiac Event in 80 participants. Completed in 9 February 2020.
9 February 2020
Quick facts
| Lead sponsor | Sheffield Teaching Hospitals NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 13 September 2016 |
| Primary completion | 9 February 2020 |
| Estimated completion | 9 February 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Bilateral Internal Mammary Artery grafts
- Prevena
Conditions studied
- Cardiac Event — all drugs for Cardiac Event →
- Arrest; Cardiac, Complicating Surgery — all drugs for Arrest; Cardiac, Complicating Surgery →
- Coronary Bypass Graft Stenosis — all drugs for Coronary Bypass Graft Stenosis →
- Complication of Coronary Artery Bypass Graft — all drugs for Complication of Coronary Artery Bypass Graft →
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Who can join
18 and older, any sex, with Cardiac Event or Arrest; Cardiac, Complicating Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The question this research project wants to explore is whether using the Prevena Incision Management System (Prevena) will improve sternal wound edge oxygenation in patients undergoing Coronary Artery bypass surgery with Bilateral Internal Mammary Artery grafts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02814084
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Event
Currently open trials in the same condition.
- NCT04696523 — Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage · Phase 2 · recruiting
- NCT06666400 — Living Healthy for Moms RCT · NA · active not recruiting
Other Sheffield Teaching Hospitals NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07407712 — Better Outcomes Through Optimal Sleep in Surgical Training · NA · recruiting
- NCT07172555 — Virtual Dietetic Interventions in Patients With Coeliac · NA · recruiting
- NCT06310993 — Exercise to Boost Immunity in Advanced Cancer · NA · not yet recruiting
- NCT06905405 — The Use of Advanced Imaging in HFpEF · recruiting
- NCT06633627 — Neurological Responses in Patients with Dentine Hypersensitivity · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02814084 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sheffield Teaching Hospitals NHS Foundation Trust
- Last refreshed: 24 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02814084.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing